Skip Navigation Change Font Size

Audit (A-07-13-06041)

07-31-2014
The Centers for Medicare & Medicaid Services Provided Medicare Part D Coverage to Beneficiaries Confined in Mental Health Facilities for Court-Ordered Purposes

Complete Report

Download the complete report

Adobe® Acrobat® is required to read PDF files.

Summary

During calendar years 2006 through 2011, the Centers for Medicare & Medicaid Services (CMS) CMS accepted prescription drug event records from Medicare Part D sponsors totaling over $12.6 million on behalf of beneficiaries who were confined in mental health facilities by court order under a penal code (confined beneficiaries). Had those same persons been enrolled in Medicare Parts A or B, payment for Parts A or B services would generally not have been made. This occurred because CMS policy permits Medicare payments to be made on behalf of confined beneficiaries enrolled in Part D but not on behalf of those enrolled in Part A or Part B.

Federal regulations state that an individual is eligible for Medicare Part D benefits if he or she is entitled to benefits under Part A or enrolled in Part B and lives in the service area of a Part D plan. However, under current policy for the administration of Part D, CMS does not consider confined beneficiaries to be incarcerated for the purpose of Part D eligibility, regardless of the reason for their confinement. For Medicare Parts A and B, beneficiaries in custody of penal authorities include confined beneficiaries. Medicare generally does not pay Part A and Part B benefits to incarcerated beneficiaries, but those beneficiaries retain their entitlement to Part A and can retain their enrollment in Part B with the payment of premiums. Accordingly, these individuals would be eligible for payments under Part D

We recommend that, to be consistent with the relevant provisions of Medicare Part A and Part B, CMS revise the Manual to prohibit Part D payments made on behalf of confined beneficiaries, which could have resulted in cost savings associated with $12.6 million in gross drug costs that CMS accepted for the 6-year period we reviewed. CMS concurred with our recommendation and described corrective actions that it had taken or planned to take.

I'm Looking For

Let's start by choosing a topic

Exclusions Database Report Fraud
Newsletter Sign Up Envelop Graphic

Stay up to date on the latest OIG news and opinions

Office of Inspector General, U.S. Department of Health and Human Services | 330 Independence Avenue, SW, Washington, DC 20201